Clinical Research Directory
Browse clinical research sites, groups, and studies.
Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer
Sponsor: Samsung Medical Center
Summary
To investigate the acute toxicities, late toxicities, and treatment results when the early cervical cancer patients are treated by hypofractionated intensity-modulated radiotherapy (2.5 Gy X 16 fractions, once a day) after radical hysterectomy.
Official title: Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer: a Prospective Exploratory Trial (POHIM_RT Trial)
Key Details
Gender
FEMALE
Age Range
20 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2017-08-31
Completion Date
2025-04-28
Last Updated
2025-01-03
Healthy Volunteers
Yes
Interventions
POHIM-RT
postoperative adjuvant IMRT with hypofractionation (2.5 Gy/fraction, 16 fractions, once a day)
Locations (1)
Samsung Medical Center
Seoul, South Korea